Among nine tumors (BLCA, KIRC, KIRP, LIHC, LUAD, PAAD, PCPG, THCA, and UCEC), high expression of IGF2BP1/2/3 was identified as risk factors for poor prognosis in patients (Fig. 3A). This evidence concerns the gene IGF2BP1 and bladder transitional cell carcinoma.